Beutel, Goodman & Co Ltd.
- SEC CIK
- 0001361974
- Latest filing
- Aug 12, 2026
ABT holding history
Abbott Laboratories in every 13F filed by Beutel, Goodman & Co Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q2 2026 holdings
- Shares (Q2 2026)
- 23,670
- Value
- $2.15M
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 23,670 | $2.15M | <0.1% | −900−3.7% | Reduced | Holders |
| Q1 2026 | 24,570 | $2.52M | <0.1% | −1,530−5.9% | Reduced | Holders |
| Q4 2025 | 26,100 | $3.27M | <0.1% | −1,300−4.7% | Reduced | Holders |
| Q3 2025 | 27,400 | $3.67M | <0.1% | −200−0.7% | Reduced | Holders |
| Q2 2025 | 27,600 | $3.75M | <0.1% | −7,198−20.7% | Reduced | Holders |
| Q1 2025 | 34,798 | $4.62M | <0.1% | +33,298+2,219.9% | Added | Holders |
| Q4 2024 | 1,500 | $169.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 1,500 | $171.0K | <0.1% | +1,500 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −200−100.0% | Sold out | Holders |
| Q4 2022 | 200 | $21.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 200 | $19.0K | <0.1% | +200 | New | Holders |